{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T00:29:42Z","timestamp":1716078582878},"reference-count":71,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T00:00:00Z","timestamp":1379548800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0075067","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T01:12:40Z","timestamp":1379639560000},"page":"e75067","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Ocular Expression and Distribution of Products of the POAG-Associated Chromosome 9p21 Gene Region"],"prefix":"10.1371","volume":"8","author":[{"given":"Glyn","family":"Chidlow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P. M.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiwani","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Dimasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn P.","family":"Burdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Casson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie E.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,9,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Chidlow G, Wood JP, Casson RJ (2007) Pharmacological neuroprotection for glaucoma. Drugs 67\u2236725\u2013759.","DOI":"10.2165\/00003495-200767050-00006"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Mitchell P, Smith W, Attebo K, Healey PR (1996) Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 103\u22361661\u20131669.","DOI":"10.1016\/S0161-6420(96)30449-1"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90\u2236262\u2013267.","DOI":"10.1136\/bjo.2005.081224"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Monemi S, Spaeth G, DaSilva A, Popinchalk S, Ilitchev E, <etal>et al<\/etal>.. (2005) Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum Mol Genet 14\u2236725\u2013733.","DOI":"10.1093\/hmg\/ddi068"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Thorleifsson G, Walters GB, Hewitt AW, Masson G, Helgason A, <etal>et al<\/etal>.. (2010) Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nat Genet 42\u2236906\u2013909.","DOI":"10.1038\/ng.661"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Wiggs JL, Kang JH, Yaspan BL, Mirel DB, Laurie C, <etal>et al<\/etal>.. (2011) Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma in Caucasians from the USA. Hum Mol Genet 20\u22364707\u20134713.","DOI":"10.1093\/hmg\/ddr382"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Burdon KP, Macgregor S, Hewitt AW, Sharma S, Chidlow G, <etal>et al<\/etal>.. (2011) Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat Genet 43\u2236574\u2013578.","DOI":"10.1038\/ng.824"},{"key":"ref8","unstructured":"Gibson J, Griffiths H, De Salvo G, Cole M, Jacob A, <etal>et al<\/etal>.. (2012) Genome-wide association study of primary open angle glaucoma risk and quantitative traits. Mol Vis 18\u22361083\u20131092."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e1002611","DOI":"10.1371\/journal.pgen.1002611","article-title":"Common genetic determinants of intraocular pressure and primary open-angle glaucoma","volume":"8","author":"LM van Koolwijk","year":"2012","journal-title":"PLoS Genet"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Sharma S, Burdon KP, Chidlow G, Klebe S, Crawford A, <etal>et al<\/etal>.. (2012) Association of genetic variants in the TMCO1 gene with clinical parameters related to glaucoma and characterization of the protein in the eye. Invest Ophthalmol Vis Sci 53\u22364917\u20134925.","DOI":"10.1167\/iovs.11-9047"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Burdon KP, Crawford A, Casson RJ, Hewitt AW, Landers J, <etal>et al<\/etal>.. (2012) Glaucoma Risk Alleles at CDKN2B-AS1 Are Associated with Lower Intraocular Pressure, Normal-Tension Glaucoma, and Advanced Glaucoma. Ophthalmology 119\u22361539\u20131545.","DOI":"10.1016\/j.ophtha.2012.02.004"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e39278","DOI":"10.1371\/journal.pone.0039278","article-title":"CDKN2B polymorphism is associated with primary open-angle glaucoma (POAG) in the Afro-Caribbean population of Barbados, West Indies","volume":"7","author":"D Cao","year":"2012","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Fan BJ, Wang DY, Pasquale LR, Haines JL, Wiggs JL (2011) Genetic variants associated with optic nerve vertical cup-to-disc ratio are risk factors for primary open angle glaucoma in a US Caucasian population. Invest Ophthalmol Vis Sci 52\u22361788\u20131792.","DOI":"10.1167\/iovs.10-6339"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Mabuchi F, Sakurada Y, Kashiwagi K, Yamagata Z, Iijima H, <etal>et al<\/etal>.. (2012) Association between Genetic Variants Associated with Vertical Cup-to-Disc Ratio and Phenotypic Features of Primary Open-Angle Glaucoma. Ophthalmology 119\u22361819\u20131825.","DOI":"10.1016\/j.ophtha.2012.02.044"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e33389","DOI":"10.1371\/journal.pone.0033389","article-title":"Common variants in CDKN2B-AS1 associated with optic-nerve vulnerability of glaucoma identified by genome-wide association studies in Japanese","volume":"7","author":"M Nakano","year":"2012","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Osman W, Low SK, Takahashi A, Kubo M, Nakamura Y (2012) A genome-wide association study in the Japanese population confirms 9p21 and 14q23 as susceptibility loci for primary open angle glaucoma. Hum Mol Genet 21\u22362836\u20132842.","DOI":"10.1093\/hmg\/dds103"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e1000978","DOI":"10.1371\/journal.pgen.1000978","article-title":"A genome-wide association study of optic disc parameters","volume":"6","author":"WD Ramdas","year":"2010","journal-title":"PLoS Genet"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Ramdas WD, van Koolwijk LM, Lemij HG, Pasutto F, Cree AJ, <etal>et al<\/etal>.. (2011) Common genetic variants associated with open-angle glaucoma. Hum Mol Genet 20\u22362464\u20132471.","DOI":"10.1093\/hmg\/ddr120"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e40107","DOI":"10.1371\/journal.pone.0040107","article-title":"Common variants on chromosome 9p21 are associated with normal tension glaucoma","volume":"7","author":"M Takamoto","year":"2012","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e1002654","DOI":"10.1371\/journal.pgen.1002654","article-title":"Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma","volume":"8","author":"JL Wiggs","year":"2012","journal-title":"PLoS Genet"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Broadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, <etal>et al<\/etal>.. (2008) Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 17\u2236806\u2013814.","DOI":"10.1093\/hmg\/ddm352"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, <etal>et al<\/etal>.. (2007) A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316\u22361491\u20131493.","DOI":"10.1126\/science.1142842"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, <etal>et al<\/etal>.. (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316\u22361488\u20131491.","DOI":"10.1126\/science.1142447"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e1000899","DOI":"10.1371\/journal.pgen.1000899","article-title":"Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression","volume":"6","author":"MS Cunnington","year":"2010","journal-title":"PLoS Genet"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Pasmant E, Sabbagh A, Vidaud M, Bieche I (2011) ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J 25\u2236444\u2013448.","DOI":"10.1096\/fj.10-172452"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Cunnington MS, Keavney B (2011) Genetic mechanisms mediating atherosclerosis susceptibility at the chromosome 9p21 locus. Curr Atheroscler Rep 13\u2236193\u2013201.","DOI":"10.1007\/s11883-011-0178-z"},{"key":"ref27","unstructured":"Sato K, Nakagawa H, Tajima A, Yoshida K, Inoue I (2010) ANRIL is implicated in the regulation of nucleus and potential transcriptional target of E2F1. Oncol Rep 24\u2236701\u2013707."},{"key":"ref28","unstructured":"Christopher SA, Diegelman P, Porter CW, Kruger WD (2002) Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a\/ARF), acts as a tumor suppressor in a breast cancer cell line. Cancer Res 62\u22366639\u20136644."},{"key":"ref29","unstructured":"Hall M, Bates S, Peters G (1995) Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11\u22361581\u20131588."},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Chidlow G, Daymon M, Wood JP, Casson RJ (2011) Localization of a wide-ranging panel of antigens in the rat retina by immunohistochemistry: comparison of Davidson\u2019s solution and formalin as fixatives. J Histochem Cytochem 59\u2236884\u2013898.","DOI":"10.1369\/0022155411418115"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Chidlow G, Ebneter A, Wood JP, Casson RJ (2011) The optic nerve head is the site of axonal transport disruption, axonal cytoskeleton damage and putative axonal regeneration failure in a rat model of glaucoma. Acta Neuropathol 121\u2236737\u2013751.","DOI":"10.1007\/s00401-011-0807-1"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72\u2236248\u2013254.","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Wood JP, Chidlow G, Graham M, Osborne NN (2005) Energy substrate requirements for survival of rat retinal cells in culture: the importance of glucose and monocarboxylates. J Neurochem 93\u2236686\u2013697.","DOI":"10.1111\/j.1471-4159.2005.03059.x"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Van Bergen NJ, Wood JP, Chidlow G, Trounce IA, Casson RJ, <etal>et al<\/etal>.. (2009) Recharacterization of the RGC-5 retinal ganglion cell line. Invest Ophthalmol Vis Sci 50\u22364267\u20134272.","DOI":"10.1167\/iovs.09-3484"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Krishnamoorthy RR, Agarwal P, Prasanna G, Vopat K, Lambert W, <etal>et al<\/etal>.. (2001) Characterization of a transformed rat retinal ganglion cell line. Brain Res Mol Brain Res 86\u22361\u201312.","DOI":"10.1016\/S0169-328X(00)00224-2"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Wood JP, Chidlow G, Tran T, Crowston J, Casson RJ (2010) A Comparison of Differentiation Protocols for Rgc-5 Cells. Invest Ophthalmol Vis Sci 51\u22363774\u20133783.","DOI":"10.1167\/iovs.09-4305"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"E96","DOI":"10.1111\/j.1365-2559.2012.04196.x","article-title":"The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomas","volume":"60","author":"ZG Zimling","year":"2012","journal-title":"Histopathology"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Mulvany NJ, Allen DG, Wilson SM (2008) Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies. Pathology 40\u2236335\u2013344.","DOI":"10.1080\/00313020802035907"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen N, Koliopoulos G, <etal>et al<\/etal>.. (2009) p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev 35\u2236210\u2013220.","DOI":"10.1016\/j.ctrv.2008.10.005"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Sano T, Masuda N, Oyama T, Nakajima T (2002) Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int 52\u2236375\u2013383.","DOI":"10.1046\/j.1440-1827.2002.01359.x"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Bulten J, van der Avoort IA, Melchers WJ, Massuger LF, Grefte JM, <etal>et al<\/etal>.. (2006) p14ARF and p16INK4A, two products of the same gene, are differently expressed in cervical intraepithelial neoplasia. Gynecol Oncol 101\u2236487\u2013494.","DOI":"10.1016\/j.ygyno.2005.11.036"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Qi Y, Gregory MA, Li Z, Brousal JP, West K, <etal>et al<\/etal>.. (2004) p19ARF directly and differentially controls the functions of c-Myc independently of p53. Nature 431\u2236712\u2013717.","DOI":"10.1038\/nature02958"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Awad MM, Sanders JA, Gruppuso PA (2000) A potential role for p15(Ink4b) and p57(Kip2) in liver development. FEBS Lett 483\u2236160\u2013164.","DOI":"10.1016\/S0014-5793(00)02108-6"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Feng W, Xiao J, Zhang Z, Rosen DG, Brown RE, <etal>et al<\/etal>.. (2007) Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma. Mod Pathol 20\u2236961\u2013966.","DOI":"10.1038\/modpathol.3800927"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Moad AI, Lan TM, Kaur G, Hashim H, Mabruk MJ (2009) Immunohistochemical determination of the P15 protein expression in cutaneous squamous cell carcinoma. J Cutan Pathol 36\u2236183\u2013189.","DOI":"10.1111\/j.1600-0560.2008.00989.x"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, <etal>et al<\/etal>.. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316\u22361341\u20131345.","DOI":"10.1126\/science.1142382"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Rhodes KJ, Trimmer JS (2006) Antibodies as valuable neuroscience research tools versus reagents of mass distraction. J Neurosci 26\u22368017\u20138020.","DOI":"10.1523\/JNEUROSCI.2728-06.2006"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Fritschy JM (2008) Is my antibody-staining specific? How to deal with pitfalls of immunohistochemistry. Eur J Neurosci 28\u22362365\u20132370.","DOI":"10.1111\/j.1460-9568.2008.06552.x"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Saper CB (2005) An open letter to our readers on the use of antibodies. J Comp Neurol 493\u2236477\u2013478.","DOI":"10.1002\/cne.20839"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Burry RW (2011) Controls for immunocytochemistry: an update. J Histochem Cytochem 59\u22366\u201312.","DOI":"10.1369\/jhc.2010.956920"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Williams-Ashman HG, Seidenfeld J, Galletti P (1982) Trends in the biochemical pharmacology of 5\u2032-deoxy-5\u2032-methylthioadenosine. Biochem Pharmacol 31\u2236277\u2013288.","DOI":"10.1016\/0006-2952(82)90171-X"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Garbers DL (1978) Demonstration of 5\u2032-methylthioadenosine phosphorylase activity in various rat tissues. Biochimica et Biophysica Acta 523\u223682\u201393.","DOI":"10.1016\/0005-2744(78)90011-6"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Huang HY, Li SH, Yu SC, Chou FF, Tzeng CC, <etal>et al<\/etal>.. (2009) Homozygous deletion of MTAP gene as a poor prognosticator in gastrointestinal stromal tumors. Clin Cancer Res 15\u22366963\u20136972.","DOI":"10.1158\/1078-0432.CCR-09-1511"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Kim J, Kim MA, Min SY, Jee CD, Lee HE, <etal>et al<\/etal>.. (2011) Downregulation of methylthioadenosin phosphorylase by homozygous deletion in gastric carcinoma. Genes Chromosomes Cancer 50\u2236421\u2013433.","DOI":"10.1002\/gcc.20867"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Sommer J, Itani DM, Homlar KC, Keedy VL, Halpern JL, <etal>et al<\/etal>.. (2010) Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor\/insulin receptor: potential therapeutic targets in chordoma. J Pathol 220\u2236608\u2013617.","DOI":"10.1002\/path.2679"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Romagosa C, Simonetti S, Lopez-Vicente L, Mazo A, Lleonart ME, <etal>et al<\/etal>.. (2011) p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors. Oncogene 30\u22362087\u20132097.","DOI":"10.1038\/onc.2010.614"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Liggett WH Jr, Sidransky D (1998) Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 16\u22361197\u20131206.","DOI":"10.1200\/JCO.1998.16.3.1197"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Robertson KD, Jones PA (1999) Tissue-specific alternative splicing in the human INK4a\/ARF cell cycle regulatory locus. Oncogene 18\u22363810\u20133820.","DOI":"10.1038\/sj.onc.1202737"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Zindy F, Quelle DE, Roussel MF, Sherr CJ (1997) Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15\u2236203\u2013211.","DOI":"10.1038\/sj.onc.1201178"},{"key":"ref60","unstructured":"Quelle DE, Ashmun RA, Hannon GJ, Rehberger PA, Trono D, <etal>et al<\/etal>.. (1995) Cloning and characterization of murine p16INK4a and p15INK4b genes. Oncogene 11\u2236635\u2013645."},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Watanabe G, Pena P, Shambaugh GE 3rd, Haines GK 3rd, Pestell RG (1998) Regulation of cyclin dependent kinase inhibitor proteins during neonatal cerebella development. Brain Res Dev Brain Res 108\u223677\u201387.","DOI":"10.1016\/S0165-3806(98)00032-7"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Dimaras H, Khetan V, Halliday W, Orlic M, Prigoda NL, <etal>et al<\/etal>.. (2008) Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet 17\u22361363\u20131372.","DOI":"10.1093\/hmg\/ddn024"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Indovina P, Acquaviva A, De Falco G, Rizzo V, Onnis A, <etal>et al<\/etal>.. (2010) Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma. J Cell Physiol 223\u2236143\u2013150.","DOI":"10.1002\/jcp.22019"},{"key":"ref64","unstructured":"Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, <etal>et al<\/etal>.. (1995) A novel p16INK4A transcript. Cancer Res 55\u22362995\u20132997."},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Quelle DE, Zindy F, Ashmun RA, Sherr CJ (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83\u2236993\u20131000.","DOI":"10.1016\/0092-8674(95)90214-7"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Bates S, Phillips AC, Clark PA, Stott F, Peters G, <etal>et al<\/etal>.. (1998) p14ARF links the tumour suppressors RB and p53. Nature 395\u2236124\u2013125.","DOI":"10.1038\/25867"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Stott FJ, Bates S, James MC, McConnell BB, Starborg M, <etal>et al<\/etal>.. (1998) The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 17\u22365001\u20135014.","DOI":"10.1093\/emboj\/17.17.5001"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Sandhu C, Garbe J, Bhattacharya N, Daksis J, Pan CH, <etal>et al<\/etal>.. (1997) Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol Cell Biol 17\u22362458\u20132467.","DOI":"10.1128\/MCB.17.5.2458"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Krimpenfort P, Ijpenberg A, Song JY, van der Valk M, Nawijn M, <etal>et al<\/etal>.. (2007) p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature 448\u2236943\u2013946.","DOI":"10.1038\/nature06084"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Fuchshofer R, Tamm ER (2012) The role of TGF-beta in the pathogenesis of primary open-angle glaucoma. Cell Tissue Res 347\u2236279\u2013290.","DOI":"10.1007\/s00441-011-1274-7"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Legrier ME, Ducray A, Propper A, Kastner A (2001) Region-specific expression of cell cycle inhibitors in the adult brain. Neuroreport 12\u22363127\u20133131.","DOI":"10.1097\/00001756-200110080-00029"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0075067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:19:38Z","timestamp":1715991578000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0075067"}},"subtitle":[],"editor":[{"given":"Balraj","family":"Mittal","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,9,19]]},"references-count":71,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0075067","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,19]]}}}